---
title: "Mentari Therapeutics Files Initial Beneficial Ownership Statement for Director Julianne Bruno"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305368358.md"
description: "Mentari Therapeutics director Julianne Bruno filed an initial beneficial ownership statement disclosing direct ownership of 33,442 shares of common stock. The filing was published via EDGAR on November 12, 2026."
datetime: "2026-11-12T21:01:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305368358.md)
  - [en](https://longbridge.com/en/news/305368358.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305368358.md)
generator: "portal-rs"
---

# Mentari Therapeutics Files Initial Beneficial Ownership Statement for Director Julianne Bruno

-   Mentari Therapeutics director Julianne Bruno disclosed direct ownership of 33,442 shares of common stock in an initial beneficial ownership filing. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mentari Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-458257), on November 12, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [MTRI.US](https://longbridge.com/en/quote/MTRI.US.md)

## Related News & Research

- [Mentari Therapeutics' Total Liabilities Rise to $78.61 Million From $10.26 Million at Year-End](https://longbridge.com/en/news/305668280.md)
- [Wedbush initiates coverage of Mentari Therapeutics at Outperform, sets price target at $33](https://longbridge.com/en/news/305469432.md)
- [MTRI: PACAP/CGRP pipeline targets more effective, less frequent migraine prevention](https://longbridge.com/en/news/305818527.md)
- [Mentari Therapeutics Presents Migraine Drug Pipeline, Targets First Clinical Data in 2027](https://longbridge.com/en/news/304878301.md)
- [ADAR1 Capital Management reports acquisition of $34,571.592 in Mentari Therapeutics common shares](https://longbridge.com/en/news/304932745.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**